Categories and tags
- From the Industry (2)
- From the Literature (1,036)
- News (19)
- Other NATA Events (4)
- Past NATA Symposia (20)
- Reviewed articles (39)
- Unclassed (21)
ACTIVATED FACTOR-VII ACUTE NORMOVOLEMIC HEMODILUTION ANEMIA ANH autologous blood autotransfusion bleeding BLOOD BLOOD-COAGULATION BLOOD-TRANSFUSION blood loss blood substitutes CANCER CARDIAC-SURGERY cardiopulmonary bypass COAGULATION EFFICACY erythropoietin Factor VIIa HEMODILUTION hemophilia HEMOPHILIA-A HEMORRHAGE hemostasis INHIBITORS MANAGEMENT NovoSeven NOVOSEVEN(R) oncology oxygen carriers PATIENT PLASMA RECOMBINANT-HUMAN-ERYTHROPOIETIN RECOMBINANT FACTOR VIIA rFVIIa RISK risks safety SURGERY survival THERAPY TISSUE FACTOR TRANSFUSION Trauma TRIAL
Most recent posts
Zeroual and colleagues report the results of a single-centre, single-blinded randomised controlled study of cardiac surgery patients comparing two strategies…
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study.
Surgical patients may be at high risk of venous thromboembolism (VTE). SARS‐CoV‐2 infection has been shown to increase this risk. In…
Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial.
Current approaches to trauma resuscitation focus on the timely control of bleeding and correction of trauma-induced coagulopathy using the administration…
Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial.
Perioperative iron – There is no easy answer Intravenous (IV) iron is a major cornerstone of every PBM programme. It…